002793 罗欣药业
交易中 07-30 11:06:03
资讯
新帖
简况
医药电商概念盘中拉升,罗欣药业涨7.87%
市场透视 · 01:36
医药电商概念盘中拉升,罗欣药业涨7.87%
异动快报:罗欣药业(002793)7月29日10点27分触及涨停板
证券之星 · 07-29 02:30
异动快报:罗欣药业(002793)7月29日10点27分触及涨停板
罗欣药业(002793)股东山东罗欣控股有限公司质押2500万股,占总股本2.3%
证券之星 · 07-21
罗欣药业(002793)股东山东罗欣控股有限公司质押2500万股,占总股本2.3%
罗欣药业:公司不存在逾期对外担保
证券日报 · 07-17
罗欣药业:公司不存在逾期对外担保
罗欣药业:相关信息与事实严重不符
证券之星 · 07-11
罗欣药业:相关信息与事实严重不符
罗欣药业最新公告:预计上半年净利润1500万元-2000万元 同比扭亏为盈
证券之星 · 07-11
罗欣药业最新公告:预计上半年净利润1500万元-2000万元 同比扭亏为盈
罗欣药业:截至目前股东总户数为36,524
证券之星 · 07-03
罗欣药业:截至目前股东总户数为36,524
化学制药行业2日主力净流出17.04亿元,罗欣药业、上海谊众居前
金融界 · 07-02
化学制药行业2日主力净流出17.04亿元,罗欣药业、上海谊众居前
罗欣药业(002793)股东山东罗欣控股有限公司质押3602万股,占总股本3.31%
证券之星 · 06-30
罗欣药业(002793)股东山东罗欣控股有限公司质押3602万股,占总股本3.31%
罗欣药业最新公告:股东拟减持不超过0.97%公司股份
证券之星 · 06-12
罗欣药业最新公告:股东拟减持不超过0.97%公司股份
异动快报:罗欣药业(002793)6月9日9点46分触及涨停板
证券之星 · 06-09
异动快报:罗欣药业(002793)6月9日9点46分触及涨停板
罗欣药业:截止至 2025年5月20日,公司股东总户数为30,732
证券之星 · 06-04
罗欣药业:截止至 2025年5月20日,公司股东总户数为30,732
每周股票复盘:罗欣药业(002793)布洛芬注射液获批视同通过一致性评价
证券之星 · 05-31
每周股票复盘:罗欣药业(002793)布洛芬注射液获批视同通过一致性评价
罗欣药业:公司始终坚持依法履行信息披露义务并积极披露重要信息
证券之星 · 05-29
罗欣药业:公司始终坚持依法履行信息披露义务并积极披露重要信息
罗欣药业(002793.SZ):布洛芬注射用浓溶液获药品注册证书
智通财经 · 05-27
罗欣药业(002793.SZ):布洛芬注射用浓溶液获药品注册证书
每周股票复盘:罗欣药业(002793)现898.71万元大宗交易
证券之星 · 05-24
每周股票复盘:罗欣药业(002793)现898.71万元大宗交易
5月23日罗欣药业现898.71万元大宗交易
证券之星 · 05-23
5月23日罗欣药业现898.71万元大宗交易
罗欣药业5月23日现1笔大宗交易 总成交金额898.71万元 溢价率为-0.90%
新浪证券-红岸工作室 · 05-23
罗欣药业5月23日现1笔大宗交易 总成交金额898.71万元 溢价率为-0.90%
罗欣药业:截止至2025年5月20日公司股东总户数为30732
证券之星 · 05-22
罗欣药业:截止至2025年5月20日公司股东总户数为30732
罗欣药业最新公告:合计持股5%以上股东终止协议转让公司部分股份
证券之星 · 05-16
罗欣药业最新公告:合计持股5%以上股东终止协议转让公司部分股份
加载更多
公司概况
公司名称:
罗欣药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2016-04-15
主营业务:
罗欣药业集团股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是替戈拉生片、注射用美罗培南、奥美拉唑肠溶胶囊、注射用头孢呋辛钠、注射用头孢美唑钠、注射用克林霉素磷酸酯、注射用谷胱甘肽、注射用盐酸氨溴索、注射用雷贝拉唑钠。2024年度制药工业企业营业收入前百家、“2023—2024年医药行业自主创新前五十家企业”、“头部力量医药高质量发展成果企业(2023)”、“山东省支柱型雁阵集群‘头雁’企业”、“山东省民营企业创新百强”。
发行价格:
11.97
{"stockData":{"symbol":"002793","market":"SZ","secType":"STK","nameCN":"罗欣药业","latestPrice":6.16,"timestamp":1753844763000,"preClose":5.97,"halted":0,"volume":109806302,"delay":0,"changeRate":0.0318,"floatShares":1086000000,"shares":1088000000,"eps":-0.8489,"marketStatus":"交易中","change":0.19,"latestTime":"07-30 11:06:03","open":6.07,"high":6.49,"low":6.02,"amount":686000000,"amplitude":0.0787,"askPrice":6.16,"askSize":240,"bidPrice":6.15,"bidSize":580,"shortable":0,"etf":0,"ttmEps":-0.8489,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1753846200000},"marketStatusCode":2,"adr":0,"adjPreClose":5.97,"symbolType":"stock","openAndCloseTimeList":[[1753839000000,1753846200000],[1753851600000,1753858800000]],"highLimit":6.57,"lowLimit":5.37,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1087588486,"isCdr":false,"pbRate":4.65,"roa":"--","roe":"0.41%","epsLYR":-0.91,"committee":0.024402,"marketValue":6700000000,"turnoverRate":0.1011,"status":0,"floatMarketCap":6689000000},"requestUrl":"/m/hq/s/002793","defaultTab":"news","newsList":[{"id":"2555980900","title":"医药电商概念盘中拉升,罗欣药业涨7.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555980900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555980900?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:36","pubTimestamp":1753839403,"startTime":"0","endTime":"0","summary":"07月30日,医药电商概念盘中拉升,截至09点36分,医药电商概念整体指数上涨0.84%,报1252.960点。从个股上来看,该概念的成分股中,罗欣药业涨7.87%,金石亚药涨幅超过5%。从资金上来看,截止发稿,医药电商概念主力净流入为-2.16亿,其中康美药业受到资金热捧,主力净流入1204.88万;拉长时间线来看,该板块近20日主力资金净流入-77.34亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507300936439726a08b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507300936439726a08b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600518","BK0077","BK0201","BK0239","BK0012","BK0001","002793","BK0183","BK0096","BK0028","BK0175","BK0187","BK0188","BK0146","BK0097","BK0196","BK0132"],"gpt_icon":0},{"id":"2555085764","title":"异动快报:罗欣药业(002793)7月29日10点27分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2555085764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555085764?lang=zh_cn&edition=full","pubTime":"2025-07-29 10:30","pubTimestamp":1753756242,"startTime":"0","endTime":"0","summary":"证券之星7月29日盘中消息,10点27分罗欣药业触及涨停板。目前价格5.97,上涨9.94%。其所属行业化学制药目前上涨。领涨股为亚太药业。该股为创新药,化学原料药,幽门螺杆菌概念概念热股,当日创新药概念上涨1.81%,化学原料药概念上涨0.97%,幽门螺杆菌概念概念上涨0.82%。7月28日的资金流向数据方面,主力资金净流入242.26万元,占总成交额1.27%,游资资金净流入437.62万元,占总成交额2.3%,散户资金净流出679.88万元,占总成交额3.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900012649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","BK0001","002793","08058","BK0132"],"gpt_icon":0},{"id":"2553040513","title":"罗欣药业(002793)股东山东罗欣控股有限公司质押2500万股,占总股本2.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553040513","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553040513?lang=zh_cn&edition=full","pubTime":"2025-07-22 00:23","pubTimestamp":1753115003,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业7月22日公开信息显示,股东山东罗欣控股有限公司向深圳市佳银典当有限公司合计质押2500.0万股,占总股本2.3%。质押详情见下表:截止本公告日,股东山东罗欣控股有限公司已累计质押股份1.63亿股,占其持股总数的68.98%。罗欣药业主营业务:医药产品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072200000732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0201","002793","BK0132","BK0239","08058"],"gpt_icon":0},{"id":"2552433317","title":"罗欣药业:公司不存在逾期对外担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2552433317","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552433317?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:13","pubTimestamp":1752761580,"startTime":"0","endTime":"0","summary":"证券日报网讯 7月17日晚间,罗欣药业(维权)发布公告称,公司不存在逾期对外担保,无涉及诉讼的担保及因担保被判决败诉而承担损失的情形。(文章来源:证券日报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-07-17/doc-inffuzvm7188735.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-07-17/doc-inffuzvm7188735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0001","08058","BK0201","BK0132","002793","BK0239"],"gpt_icon":0},{"id":"2550956821","title":"罗欣药业:相关信息与事实严重不符","url":"https://stock-news.laohu8.com/highlight/detail?id=2550956821","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550956821?lang=zh_cn&edition=full","pubTime":"2025-07-11 20:51","pubTimestamp":1752238298,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)07月10日在投资者关系平台上答复投资者关心的问题。投资者提问:本人在贵司百度贴吧看到一份题为《见日资本和罗欣药业不快乐的一段近事》图文,请问是否属实,贵司实控人是否有做出有损商业基本道德的事情罗欣药业回复:尊敬的投资者,您好!经与公司实控人核实,以上信息与事实严重不符。目前百度贴吧已将相关图文信息删除。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100038650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0201","BK0239","08058","BK0132","002793"],"gpt_icon":0},{"id":"2550933385","title":"罗欣药业最新公告:预计上半年净利润1500万元-2000万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2550933385","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550933385?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:57","pubTimestamp":1752224260,"startTime":"0","endTime":"0","summary":"罗欣药业(002793.SZ)发布2025年上半年业绩预告,预计归属于上市公司股东的净利润为1500万元-2000万元,同比扭亏为盈。报告期内,公司核心创新药产品替戈拉生片商业化进程加快,终端覆盖扩大带动销量增长;同时优化营运资金管理,加强应收账款清收,改善现金流并减少坏账损失。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100027148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","002793"],"gpt_icon":0},{"id":"2548802500","title":"罗欣药业:截至目前股东总户数为36,524","url":"https://stock-news.laohu8.com/highlight/detail?id=2548802500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548802500?lang=zh_cn&edition=full","pubTime":"2025-07-03 20:52","pubTimestamp":1751547153,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)07月03日在投资者关系平台上答复投资者关心的问题。投资者提问:截至到2025年6月10日贵公司的股东人数是多少?罗欣药业回复:尊敬的投资者,您好!截至目前,公司最新一期(2025年6月30日)股东总户数为36,524。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300036301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0239","BK0001","BK0132","BK0201","08058"],"gpt_icon":0},{"id":"2548865828","title":"化学制药行业2日主力净流出17.04亿元,罗欣药业、上海谊众居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2548865828","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548865828?lang=zh_cn&edition=full","pubTime":"2025-07-02 15:46","pubTimestamp":1751442364,"startTime":"0","endTime":"0","summary":"7月2日,化学制药行业下跌0.82%,今日主力资金流出17.04亿元,成分股32只上涨,64只下跌。主力资金净流出居前的分别为罗欣药业、上海谊众、恩华药业、万邦德、健友股份。序号代码名称最新价涨跌幅主力净流入主力净占比1603538美诺华23.1810.011.43亿元11.88%2002365永安药业28.260.218400.99万元4.58%3603367辰欣药业14.723.373101.91万元12.21%4002900哈三联15.65.263011.73万元4.56%5603811诚意药业10.4510.02931.27万元25.53%6688166博瑞医药52.89-2.381995.23万元9.5%7000915华特达因33.22-4.071991.85万元6.24%8603520司太立10.041.211289.77万元12.16%9000953河化股份7.415.411169.23万元2.34%10000813德展健康3.270.621052.17万元11.1%","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/02154651438387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0001","BK1574","BK0201","BK0239","08058","BK1191","01477","BK0132","002793","688091"],"gpt_icon":0},{"id":"2548301166","title":"罗欣药业(002793)股东山东罗欣控股有限公司质押3602万股,占总股本3.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548301166","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548301166?lang=zh_cn&edition=full","pubTime":"2025-07-01 00:24","pubTimestamp":1751300677,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业7月1日公开信息显示,股东山东罗欣控股有限公司向浙江炳炳典当有限公司合计质押3602.0万股,占总股本3.31%。质押详情见下表:截止本公告日,股东山东罗欣控股有限公司已累计质押股份1.55亿股,占其持股总数的65.4%。罗欣药业主营业务:医药产品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100001033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","08058","BK0201","BK0132","002793","BK0239"],"gpt_icon":0},{"id":"2542461519","title":"罗欣药业最新公告:股东拟减持不超过0.97%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2542461519","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542461519?lang=zh_cn&edition=full","pubTime":"2025-06-12 20:01","pubTimestamp":1749729663,"startTime":"0","endTime":"0","summary":"罗欣药业(002793.SZ)公告称,公司持股5%以上股东方秀宝及其一致行动人方东晖、温岭市大任企业管理有限公司合计持有公司股份131,620,846股,占剔除回购专用账户后的总股本比例12.19%。大任管理拟通过集中竞价交易或大宗交易方式合计减持公司股份数量不超过10,442,080股,占公司总股本比例0.96%,占剔除回购专用账户后的总股本比例0.97%。减持期间为公告披露日起15个交易日后的三个月内。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061200031602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0239","BK0132","002793","08058","BK0201"],"gpt_icon":0},{"id":"2542545873","title":"异动快报:罗欣药业(002793)6月9日9点46分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2542545873","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542545873?lang=zh_cn&edition=full","pubTime":"2025-06-09 09:50","pubTimestamp":1749433844,"startTime":"0","endTime":"0","summary":"证券之星6月9日盘中消息,9点46分罗欣药业触及涨停板。目前价格5.26,上涨10.04%。其所属行业化学制药目前上涨。领涨股为海辰药业。该股为化学原料药,创新药,医药概念热股,当日化学原料药概念上涨2.53%,创新药概念上涨2.37%,医药概念上涨2.04%。6月6日的资金流向数据方面,主力资金净流入401.49万元,占总成交额2.6%,游资资金净流入319.06万元,占总成交额2.06%,散户资金净流出720.55万元,占总成交额4.66%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060900003536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","08058","BK0001","BK0201","002793"],"gpt_icon":0},{"id":"2540406618","title":"罗欣药业:截止至 2025年5月20日,公司股东总户数为30,732","url":"https://stock-news.laohu8.com/highlight/detail?id=2540406618","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540406618?lang=zh_cn&edition=full","pubTime":"2025-06-04 20:57","pubTimestamp":1749041845,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)06月04日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年5月20日A股股东人数是多少?谢谢罗欣药业回复:尊敬的投资者,您好!截止至 2025年5月20日,公司股东总户数为30,732。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400036511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","002793","BK0239","BK0132","BK0001","BK0201"],"gpt_icon":0},{"id":"2539209815","title":"每周股票复盘:罗欣药业(002793)布洛芬注射液获批视同通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2539209815","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539209815?lang=zh_cn&edition=full","pubTime":"2025-05-31 08:29","pubTimestamp":1748651383,"startTime":"0","endTime":"0","summary":"截至2025年5月30日收盘,罗欣药业报收于4.61元,较上周的4.42元上涨4.3%。近日,罗欣药业集团股份有限公司下属子公司山东罗欣药业集团股份有限公司收到国家药品监督管理局核准签发的布洛芬注射用浓溶液《药品注册证书》。审批结论为符合药品注册的有关要求,批准注册,发给药品注册证书。公司布洛芬注射用浓溶液获得药品注册证书,视同通过仿制药质量和疗效一致性评价,适用于成人发热的退热治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053100008331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0001","BK0239","08058","BK0201","BK0132"],"gpt_icon":0},{"id":"2539263871","title":"罗欣药业:公司始终坚持依法履行信息披露义务并积极披露重要信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2539263871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539263871?lang=zh_cn&edition=full","pubTime":"2025-05-29 20:55","pubTimestamp":1748523331,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业05月28日在投资者关系平台上答复投资者关心的问题。公司始终坚持按照相关法律法规、规范性文件及内部制度的要求,依法履行信息披露义务,并积极结合医药行业特点,有针对性地披露公司产品研发进展、获批上市等有助于投资者了解公司的重要信息。公司披露的定期报告涵盖了产业信息,具体可通过巨潮资讯网查阅公司相关公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052900035421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0201","002793","BK0132","BK0239","08058"],"gpt_icon":0},{"id":"2538572844","title":"罗欣药业(002793.SZ):布洛芬注射用浓溶液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2538572844","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538572844?lang=zh_cn&edition=full","pubTime":"2025-05-27 18:12","pubTimestamp":1748340732,"startTime":"0","endTime":"0","summary":"智通财经APP讯,罗欣药业(002793.SZ)公告,公司下属子公司山东罗欣药业集团股份有限公司收到国家药品监督管理局核准签发的布洛芬注射用浓溶液《药品注册证书》。公告显示,布洛芬属非甾体类抗炎药,具有镇痛、抗炎、解热作用,是一种有效的前列腺素(PG)合成抑制剂。病原体及其毒素侵袭人体后,产生与释放内热原,使中枢合成并释放PG增多,PG是一类具有高度生物活性的物质,参与机体发热、疼痛、炎症、血栓形成、过敏等多种生理、病理过程,非甾体类抗炎药能抑制合成前列腺素所必须的环加氧酶(COX)的活性,从而阻止PG的合成来发挥其药理作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1298126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"罗欣药业(002793.SZ):布洛芬注射用浓溶液获药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","08058","002793","BK0201","BK0239","BK0001"],"gpt_icon":0},{"id":"2537919539","title":"每周股票复盘:罗欣药业(002793)现898.71万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2537919539","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537919539?lang=zh_cn&edition=full","pubTime":"2025-05-24 19:03","pubTimestamp":1748084596,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘,罗欣药业(002793)报收于4.42元,较上周的4.42元上涨0.0%。本周,罗欣药业5月23日盘中最高价报4.66元。5月19日盘中最低价报4.32元。罗欣药业当前最新总市值48.07亿元,在化学制药板块市值排名89/150,在两市A股市值排名2946/5148。本周关注点交易信息汇总: 5月23日罗欣药业现898.71万元大宗交易交易信息汇总5月23日罗欣药业发生了898.71万元的大宗交易。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400013429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","08058","BK0001","BK0239","BK0201","BK0132"],"gpt_icon":0},{"id":"2537189483","title":"5月23日罗欣药业现898.71万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2537189483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537189483?lang=zh_cn&edition=full","pubTime":"2025-05-23 17:13","pubTimestamp":1747991580,"startTime":"0","endTime":"0","summary":"证券之星消息,5月23日罗欣药业发生大宗交易,交易数据如下:大宗交易成交价格4.38元,相对当日收盘价折价0.9%,成交205.18万股,成交金额898.71万元,买方营业部为中信证券股份有限公司北京总部证券营业部,卖方营业部为中信证券(山东)有限责任公司临沂金雀山路证券营业部。近三个月该股共发生1笔大宗交易,合计成交2.05万手,折价成交1笔。截至2025年5月23日收盘,罗欣药业报收于4.42元,上涨0.91%,换手率2.84%,成交量30.87万手,成交额1.39亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052300026294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK0201","BK0001","08058","002793"],"gpt_icon":0},{"id":"2537181189","title":"罗欣药业5月23日现1笔大宗交易 总成交金额898.71万元 溢价率为-0.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537181189","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537181189?lang=zh_cn&edition=full","pubTime":"2025-05-23 17:00","pubTimestamp":1747990800,"startTime":"0","endTime":"0","summary":" 5月23日,罗欣药业(维权)收涨0.91%,收盘价为4.42元,发生1笔大宗交易,合计成交量205.18万股,成交金额898.71万元。 进一步统计,近3个月内该股累计发生1笔大宗交易,合计成交金额为898.71万元。该股近5个交易日累计上涨0.00%,主力资金合计净流出2333.19万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-05-23/doc-inexpvsa6078331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0201","BK0001","002793","BK0239","BK0132","08058"],"gpt_icon":0},{"id":"2537924949","title":"罗欣药业:截止至2025年5月20日公司股东总户数为30732","url":"https://stock-news.laohu8.com/highlight/detail?id=2537924949","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537924949?lang=zh_cn&edition=full","pubTime":"2025-05-22 20:53","pubTimestamp":1747918407,"startTime":"0","endTime":"0","summary":"证券之星消息,罗欣药业(002793)05月22日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年5月20日A股股东人数是多少?谢谢罗欣药业回复:尊敬的投资者,您好!截止至 2025年5月20日,公司股东总户数为30,732。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052200035333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002793","BK0001","BK0239","08058","BK0201"],"gpt_icon":0},{"id":"2535133393","title":"罗欣药业最新公告:合计持股5%以上股东终止协议转让公司部分股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2535133393","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535133393?lang=zh_cn&edition=full","pubTime":"2025-05-16 18:50","pubTimestamp":1747392642,"startTime":"0","endTime":"0","summary":"罗欣药业(002793.SZ)公告称,公司于近日收到合计持股5%以上股东成都得怡欣华股权投资合伙企业(有限合伙)、克拉玛依市得怡欣华股权投资有限合伙企业、克拉玛依得怡健康产业投资有限合伙企业、克拉玛依得盛健康产业投资有限合伙企业的《关于协议转让终止事项的告知函》,因触发各方签署的《股份转让协议》第8.3条相关约定,本次股份转让终止。此次协议转让的股份尚未办理过户手续,未发生实质转让。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051600031373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0001","BK0239","BK0132","002793","08058"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753844765570,"stockEarnings":[{"period":"1week","weight":0.1222},{"period":"1month","weight":0.2922},{"period":"3month","weight":0.363},{"period":"6month","weight":0.6817},{"period":"1year","weight":0.5308},{"period":"ytd","weight":0.5628}],"compareEarnings":[{"period":"1week","weight":0.0078},{"period":"1month","weight":0.0542},{"period":"3month","weight":0.1008},{"period":"6month","weight":0.1105},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.077}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"罗欣药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"36039人(较上一季度减少1.33%)","perCapita":"30132股","listingDate":"2016-04-15","address":"山东省临沂市罗庄区罗七路18号4号楼","registeredCapital":"108758万元","survey":" 罗欣药业集团股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是替戈拉生片、注射用美罗培南、奥美拉唑肠溶胶囊、注射用头孢呋辛钠、注射用头孢美唑钠、注射用克林霉素磷酸酯、注射用谷胱甘肽、注射用盐酸氨溴索、注射用雷贝拉唑钠。2024年度制药工业企业营业收入前百家、“2023—2024年医药行业自主创新前五十家企业”、“头部力量医药高质量发展成果企业(2023)”、“山东省支柱型雁阵集群‘头雁’企业”、“山东省民营企业创新百强”。","listedPrice":11.97},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗欣药业,002793,罗欣药业股票,罗欣药业股票老虎,罗欣药业股票老虎国际,罗欣药业行情,罗欣药业股票行情,罗欣药业股价,罗欣药业股市,罗欣药业股票价格,罗欣药业股票交易,罗欣药业股票购买,罗欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}